Europe Hereditary Genetic Testing Market - A Regional Analysis: Focus on Products, Sample Type, Applications, and Nordic and Baltic Region, Country

1 Market Overview1.1 Market Definition1.2 Inclusions and Exclusions1.3 Current State of Hereditary Genetic Testing in Europe1.4 Market Footprint and Future Potential1.5 Realistic and Optimistic View of Europe Hereditary Genetic Testing Market

2 Industry Analysis2.1 Regulatory Framework in Europe2.1.1 Overview2.1.2 Legal Requirements2.1.3 Workflow2.1.4 Reimbursement Scenario

3 Market Dynamics3.1 Market Dynamics3.1.1 Drivers3.1.1.1 Increasing Awareness Toward Hereditary Genetic Testing3.1.1.2 Rising Prevalence of Genetic Disorders3.1.1.3 Increasing Research Funding in the Field of Genomics3.1.2 Restraints3.1.2.1 High Cost of Genetic Testing3.1.2.2 Stringent Regulatory Standards3.1.3 Opportunities3.1.3.1 Technological Advancements in the Hereditary Genetic Testing Process3.1.3.2 Growing Demand for Direct-to-Consumer (DTC) Testing Service

4 Competitive Landscape4.1 Overview4.2 Synergistic Activities4.2.1 Mergers and Acquisitions (M&A)4.2.2 New Product Launches4.2.3 Product Approvals4.2.4 Business Expansions4.3 Market Share Analysis, By Company4.4 Growth Share Analysis, By Company4.4.1 Inference4.4.2 Inference

5 Product5.1 Overview5.1.1 Kits5.1.2 Consumables5.1.3 Services5.1.4 Others

6 Sample Type6.1 Overview6.1.1 Tumor Tissue6.1.2 Bone Marrow6.1.3 Blood6.1.4 Saliva6.1.5 Others

7 Applications7.1 Overview7.1.1 Oncology Genetic Testing7.1.1.1 Overview7.1.1.2 Breast Cancer7.1.1.3 Lung Cancer7.1.1.4 Prostate Cancer7.1.1.5 Colorectal Cancer7.1.1.6 Melanoma7.1.1.7 Other Oncology Genetic Testing Type7.1.2 Cardiology Genetic Testing Type7.1.2.1 Overview7.1.2.2 Cardiomyopathy7.1.2.3 Aortopathy7.1.2.4 Arrhythmia7.1.2.5 Other Cardiology Genetic Testing Type7.1.3 Neurology Genetic Testing Type7.1.3.1 Epilepsy7.1.3.2 Neurodegenerative Disorders7.1.3.3 Neuromuscular Disorders7.1.3.4 Other Neurology Testing Type7.1.4 Newborn Screening7.1.5 Prenatal Screening and Preimplantation Testing7.1.6 Rare Disease Testing7.1.7 Direct-to-Consumer (DTC) Testing

8 Regions8.1 Europe8.1.1 Overview8.2 EU58.2.1 Germany8.2.2 U.K.8.2.3 France8.2.4 Italy8.2.5 Spain8.3 Nordic Region8.3.1 Finland8.3.1.1 Finland Hereditary Genetic Testing Market (by Product)8.3.1.2 Finland Hereditary Genetic Testing Market (by Sample Type)8.3.1.3 Finland Hereditary Genetic Testing Market (by Application)8.3.1.4 Finland Hereditary Genetic Testing Market (by Oncology Genetic Testing Application)8.3.1.5 Finland Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application)8.3.1.6 Finland Hereditary Genetic Testing Market (by Neurology Genetic Testing Application)8.3.2 Sweden8.3.2.1 Sweden Hereditary Genetic Testing Market (by Product)8.3.2.2 Sweden Hereditary Genetic Testing Market (by Sample Type)8.3.2.3 Sweden Hereditary Genetic Testing Market (by Application)8.3.2.4 Sweden Hereditary Genetic Testing Market (by Oncology Genetic Testing Application)8.3.2.5 Sweden Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application)8.3.2.6 Sweden Hereditary Genetic Testing Market (by Neurology Genetic Testing Application)8.3.3 Denmark8.3.3.1 Denmark Hereditary Genetic Testing Market (by Product)8.3.3.2 Denmark Hereditary Genetic Testing Market (by Sample Type)8.3.3.3 Denmark Hereditary Genetic Testing Market (by Application)8.3.3.4 Denmark Hereditary Genetic Testing Market (by Oncology Genetic Testing Application)8.3.3.5 Denmark Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application)8.3.3.6 Denmark Hereditary Genetic Testing Market (by Neurology Genetic Testing Application)8.3.4 Norway8.3.4.1 Norway Hereditary Genetic Testing Market (by Product)8.3.4.2 Norway Hereditary Genetic Testing Market (by Sample Type)8.3.4.3 Norway Hereditary Genetic Testing Market (by Application)8.3.4.4 Norway Hereditary Genetic Testing Market (by Oncology Genetic Testing Application)8.3.4.5 Norway Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application)8.3.4.6 Norway Hereditary Genetic Testing Market (by Neurology Genetic Testing Application)8.4 Baltic Region8.4.1 Estonia8.4.1.1 Estonia Hereditary Genetic Testing Market (by Product)8.4.1.2 Estonia Hereditary Genetic Testing Market (by Sample Type)8.4.1.3 Estonia Hereditary Genetic Testing Market (by Application)8.4.1.4 Estonia Hereditary Genetic Testing Market (by Oncology Genetic Testing Application)8.4.1.5 Estonia Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application)8.4.1.6 Estonia Hereditary Genetic Testing Market (by Neurology Genetic Testing Application)8.4.2 Lithuania8.4.2.1 Lithuania Hereditary Genetic Testing Market (by Product)8.4.2.2 Lithuania Hereditary Genetic Testing Market (by Sample Type)8.4.2.3 Lithuania Hereditary Genetic Testing Market (by Application)8.4.2.4 Lithuania Hereditary Genetic Testing Market (by Oncology Genetic Testing Application)8.4.2.5 Lithuania Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application)8.4.2.6 Lithuania Hereditary Genetic Testing Market (by Neurology Genetic Testing Application)8.4.3 Latvia8.4.3.1 Latvia Hereditary Genetic Testing Market (by Product)8.4.3.2 Latvia Hereditary Genetic Testing Market (by Sample Type)8.4.3.3 Latvia Hereditary Genetic Testing Market (by Application)8.4.3.4 Latvia Hereditary Genetic Testing Market (by Oncology Genetic Testing Application)8.4.3.5 Latvia Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application)8.4.3.6 Latvia Hereditary Genetic Testing Market (by Neurology Genetic Testing Application)8.4.4 Rest-of-Europe

9 Company Profiles9.1 Overview9.2 Agilent Technologies, Inc.9.2.1 Company Overview9.2.2 Role of Agilent Technologies, Inc. in the Europe Hereditary Genetic Testing Market9.2.3 Financials9.2.4 Key Insights About Financial Health of the Company9.2.5 SWOT Analysis9.3 Woble Helsinki Oy9.3.1 Company Overview9.3.2 Role of Woble Helsinki Oy in the Europe Hereditary Genetic Testing Market9.3.3 SWOT Analysis9.4 Negen Oy9.4.1 Company Overview9.4.2 Role of Negen Oy in the Europe Hereditary Genetic Testing Market9.4.3 SWOT Analysis9.5 Devyser9.5.1 Company Overview9.5.2 Role of Devyser in the Europe Hereditary Genetic Testing Market9.5.3 SWOT Analysis9.6 CeGat GmbH9.6.1 Company Overview9.6.2 Role of CeGaT GmbH in the Europe Hereditary Genetic Testing Market9.6.3 SWOT Analysis9.7 Beijing Genomics Institute (BGI)9.7.1 Company Overview9.7.2 Role of Beijing Genomics Institute (BGI) in the Europe Hereditary Genetic Testing Market9.7.3 SWOT Analysis9.8 BerGenBio ASA9.8.1 Company Overview9.8.2 Role of BerGenBio ASA in the Europe Hereditary Genetic Testing Market9.8.3 Financials9.8.4 SWOT Analysis9.9 Eurofins Scientific SE9.9.1 Company Overview9.9.2 Role of Eurofins Scientific SE in the Europe Hereditary Genetic Testing Market9.9.3 Financials9.9.4 SWOT Analysis9.1 F. Hoffmann-La Roche Ltd9.10.1 Company Overview9.10.2 Role of F. Hoffmann-La Roche Ltd in the Europe Hereditary Genetic Testing Market9.10.3 Financials9.10.4 Key Insights About Financial Health of the Company9.10.5 SWOT Analysis9.11 Illumina, Inc.9.11.1 Company Overview9.11.2 Role of Illumina, Inc. in the Europe Hereditary Genetic Testing Market9.11.3 Financials9.11.4 Key Insights About Financial Health of the Company9.11.5 SWOT Analysis9.12 Myriad Genetics, Inc.9.12.1 Company Overview9.12.2 Role of Myriad Genetics, Inc. in the Europe Hereditary Genetic Testing Market9.12.3 Financials9.12.4 Key Insights About Financial Health of the Company9.12.5 SWOT Analysis9.13 Alnylam Pharmaceuticals, Inc.9.13.1 Company Overview9.13.2 Role of Alnylam Pharmaceuticals, Inc., in Europe Hereditary Genetic Testing Market9.13.3 Financials9.13.4 Key Insights About Financial Health of the Company9.13.5 SWOT Analysis9.14 Quest Diagnostics Incorporated9.14.1 Company Overview9.14.2 Role of Quest Diagnostics Incorporated in the Europe Hereditary Genetic Testing Market9.14.3 Financials9.14.4 SWOT Analysis9.15 Thermo Fisher Scientific Inc.9.15.1 Company Overview9.15.2 Role of Thermo Fisher Scientific Inc. in the Europe Hereditary Genetic Testing Market9.15.3 Financials9.15.4 Key Insights About Financial Health of the Company9.15.5 SWOT Analysis

List of FiguresFigure 1: Europe Hereditary Genetic Testing Market, Realistic and Optimistic Scenario, $Million, 2020-2031Figure 2: Europe Hereditary Genetic Testing Market DynamicsFigure 3: Share of Key Market Strategies and Developments, January 2018-March 2021Figure 4: Growth Share Matrix for Europe Hereditary Genetic Testing Market (by Company), 2019 and 2020Figure 5: Growth Share Matrix for Nordic and Baltic Hereditary Genetic Testing Market (by Company), 2019 and 2020Figure 6: Europe Hereditary Genetic Testing Market Research MethodologyFigure 7: Primary Research MethodologyFigure 8: Incremental Opportunity: Europe Hereditary Genetic Testing Market, $Million, 2020-2031Figure 9: Realistic and Optimistic View of Europe Hereditary Genetic Testing Market, $Million, 2020-2031Figure 10: Europe Hereditary Genetic Testing Market DynamicsFigure 11: Share of Key Market Strategies and Developments, January 2018-March 2021Figure 12: Share of Synergistic Activities (by Company), January 2018-March 2021Figure 13: Mergers and Acquisitions (M&A) Activities, January 2018-March 2021Figure 14: New Product Launches, January 2018-March 2021Figure 15: Market Share Analysis for Europe Hereditary Genetic Testing Market, $Million, 2019 and 2020Figure 16: Market Share Analysis for Nordic and Baltic Hereditary Genetic Testing Market, 2019 and 2020Figure 17: Growth Share Matrix for Europe Hereditary Genetic Testing Market (by Company), 2019 and 2020Figure 18: Growth Share Matrix for Nordic and Baltic Hereditary Genetic Testing Market (by Company), 2019 and 2020Figure 19: Europe Hereditary Genetic Testing Market (by Product)Figure 20: Share of Europe Hereditary Genetic Testing Market (by Product), $Million, 2020 and 2031Figure 21: Share of Nordic and Baltic Hereditary Genetic Testing Market (by Product), $Million, 2020 and 2031Figure 22: Europe Hereditary Genetic Testing Market (Kits), $Million, 2020-2031Figure 23: Europe Hereditary Genetic Testing Market (Consumables), $Million, 2020-2031Figure 24: Europe Hereditary Genetic Testing Market (Services), $Million, 2020-2031Figure 25: Europe Hereditary Genetic Testing Market (Others), $Million, 2020-2031Figure 26: Europe Hereditary Genetic Testing Market (by Sample Type)Figure 27: Share of Europe Hereditary Genetic Testing Market (by Sample Type), $Million, 2020 and 2031Figure 28: Share of Nordic and Baltic Hereditary Genetic Testing Market (by Sample Type), $Million, 2020 and 2031Figure 29: Europe Hereditary Genetic Testing Market (Tumor Tissue), $Million, 2020-2031Figure 30: Europe Hereditary Genetic Testing Market (Bone Marrow), $Million, 2020-2031Figure 31: Europe Hereditary Genetic Testing Market (Blood Sample), $Million, 2020-2031Figure 32: Europe Hereditary Genetic Testing Market (Saliva), $Million, 2020-2031Figure 33: Europe Hereditary Genetic Testing Market (Others), $Million, 2020-2031Figure 34: Europe Hereditary Genetic Testing Market (by Application)Figure 35: Europe Hereditary Genetic Testing Market (by Application), $Million, 2020 and 2031Figure 36: Nordic and Baltic Hereditary Genetic Testing Market (by Application), $Million, 2020 and 2031Figure 37: Europe Hereditary Genetic Testing Market (Oncology Genetic Testing), $Million, 2020-2031Figure 38: Europe Hereditary Genetic Testing Market (Breast Cancer), $Million, 2020-2031Figure 39: Europe Hereditary Genetic Testing Market (Lung Cancer), $Million, 2020-2031Figure 40: Europe Hereditary Genetic Testing Market (Prostate Cancer), $Million, 2020-2031Figure 41: Europe Hereditary Genetic Testing Market (Colorectal Cancer), $Million, 2020-2031Figure 42: Europe Hereditary Genetic Testing Market (Melanoma), $Million, 2020-2031Figure 43: Europe Hereditary Genetic Testing Market (Other Oncology Genetic Testing), $Million, 2020-2031Figure 44: Europe Hereditary Genetic Testing Market (Cardiology Genetic Testing Type), $Million, 2020-2031Figure 45: Europe Hereditary Genetic Testing Market (Cardiomyopathy), $Million, 2020-2031Figure 46: Europe Hereditary Genetic Testing Market (Aortopathy), $Million, 2020-2031Figure 47: Europe Hereditary Genetic Testing Market (Arrhythmia), $Million, 2020-2031Figure 48: Europe Hereditary Genetic Testing Market (Other Cardiology Genetic Testing Type), $Million, 2020-2031Figure 49: Europe Hereditary Genetic Testing Market (Neurology Genetic Testing Type), $Million, 2020-2031Figure 50: Europe Hereditary Genetic Testing Market (Epilepsy), $Million, 2020-2031Figure 51: Europe Hereditary Genetic Testing Market (Neurodegenerative Disorders), $Million, 2020-2031Figure 52: Europe Hereditary Genetic Testing Market (Neuromuscular Disorders), $Million, 2020-2031Figure 53: Europe Hereditary Genetic Testing Market (Other Neurology Testing Type), $Million, 2020-2031Figure 54: Europe Hereditary Genetic Testing Market (Newborn Screening), $Million, 2020-2031Figure 55: Europe Hereditary Genetic Testing Market (Prenatal Screening and Preimplantation Testing), $Million, 2020-2031Figure 56: Europe Hereditary Genetic Testing Market (Rare Disease Testing), $Million, 2020-2031Figure 57: Europe Hereditary Genetic Testing Market (Direct-to-Consumer (DTC) Testing), $Million, 2020-2031Figure 58: Europe Hereditary Genetic Testing Market, $Million, 2020-2031Figure 59: Nordic Hereditary Genetic Testing Market, $Million, 2020-2031Figure 60: Baltic Hereditary Genetic Testing Market, $Million, 2020-2031Figure 61: Share of Europe Hereditary Genetic Testing Market (by Country), $Million, 2020-2031Figure 62: Europe: Market DynamicsFigure 63: Germany Hereditary Genetic Testing Market, $Million, 2020-2031Figure 64: U.K. Hereditary Genetic Testing Market, $Million, 2020-2031Figure 65: France Hereditary Genetic Testing Market, $Million, 2020-2031Figure 66: Italy Hereditary Genetic Testing Market, $Million, 2020-2031Figure 67: Spain Hereditary Genetic Testing Market, $Million, 2020-2031Figure 68: Finland Hereditary Genetic Testing Market, $Million, 2020-2031Figure 69: Finland Hereditary Genetic Testing Market (by Product), $Million, 2020-2031Figure 70: Finland Hereditary Genetic Testing Market (by Sample Type), $Million, 2020-2031Figure 71: Finland Hereditary Genetic Testing Market (by Application), $Million, 2020-2031Figure 72: Finland Hereditary Genetic Testing Market (by Oncology Genetic Testing Application), $Million, 2020-2031Figure 73: Finland Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application), $Million, 2020-2031Figure 74: Finland Hereditary Genetic Testing Market (by Neurology Genetic Testing Application), $Million, 2020-2031Figure 75: Sweden Hereditary Genetic Testing Market, $Million, 2020-2031Figure 76: Sweden Hereditary Genetic Testing Market (by Product), $Million, 2020-2031Figure 77: Sweden Hereditary Genetic Testing Market (by Sample Type), $Million, 2020-2031Figure 78: Sweden Hereditary Genetic Testing Market (by Application), $Million, 2020-2031Figure 79: Sweden Hereditary Genetic Testing Market (by Oncology Genetic Testing Application), $Million, 2020-2031Figure 80: Sweden Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application), $Million, 2020-2031Figure 81: Sweden Hereditary Genetic Testing Market (by Neurology Genetic Testing Application), $Million, 2020-2031Figure 82: Denmark Hereditary Genetic Testing Market, $Million, 2020-2031Figure 83: Denmark Hereditary Genetic Testing Market (by Product), $Million, 2020-2031Figure 84: Denmark Hereditary Genetic Testing Market (by Sample Type), $Million, 2020-2031Figure 85: Denmark Hereditary Genetic Testing Market (by Application), $Million, 2020-2031Figure 86: Denmark Hereditary Genetic Testing Market (by Oncology Genetic Testing Application), $Million, 2020-2031Figure 87: Denmark Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application), $Million, 2020-2031Figure 88: Denmark Hereditary Genetic Testing Market (by Neurology Genetic Testing Application), $Million, 2020-2031Figure 89: Norway Hereditary Genetic Testing Market, $Million, 2020-2031Figure 90: Norway Hereditary Genetic Testing Market (by Product), $Million, 2020-2031Figure 91: Norway Hereditary Genetic Testing Market (by Sample Type), $Million, 2020-2031Figure 92: Norway Hereditary Genetic Testing Market (by Application), $Million, 2020-2031Figure 93: Norway Hereditary Genetic Testing Market (by Oncology Genetic Testing Application), $Million, 2020-2031Figure 94: Norway Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application), $Million, 2020-2031Figure 95: Norway Hereditary Genetic Testing Market (by Neurology Genetic Testing Application), $Million, 2020-2031Figure 96: Estonia Hereditary Genetic Testing Market, $Million, 2020-2031Figure 97: Estonia Hereditary Genetic Testing Market (by Product), $Million, 2020-2031Figure 98: Estonia Hereditary Genetic Testing Market (by Sample Type), $Million, 2020-2031Figure 99: Estonia Hereditary Genetic Testing Market (by Application), $Million, 2020-2031Figure 100: Estonia Hereditary Genetic Testing Market (by Oncology Genetic Testing Application), $Million, 2020-2031Figure 101: Estonia Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application), $Million, 2020-2031Figure 102: Estonia Hereditary Genetic Testing Market (by Neurology Genetic Testing Application), $Million, 2020-2031Figure 103: Lithuania Hereditary Genetic Testing Market, $Million, 2020-2031Figure 104: Lithuania Hereditary Genetic Testing Market (by Product), $Million, 2020-2031Figure 105: Lithuania Hereditary Genetic Testing Market (by Sample Type), $Million, 2020-2031Figure 106: Lithuania Hereditary Genetic Testing Market (by Application), $Million, 2020-2031Figure 107: Lithuania Hereditary Genetic Testing Market (by Oncology Genetic Testing Application), $Million, 2020-2031Figure 108: Lithuania Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application), $Million, 2020-2031Figure 109: Lithuania Hereditary Genetic Testing Market (by Neurology Genetic Testing Application), $Million, 2020-2031Figure 110: Latvia Hereditary Genetic Testing Market, $Million, 2020-2031Figure 111: Latvia Hereditary Genetic Testing Market (by Product), $Million, 2020-2031Figure 112: Latvia Hereditary Genetic Testing Market (by Sample Type), $Million, 2020-2031Figure 113: Latvia Hereditary Genetic Testing Market (by Application), $Million, 2020-2031Figure 114: Latvia Hereditary Genetic Testing Market (by Oncology Genetic Testing Application), $Million, 2020-2031Figure 115: Latvia Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application), $Million, 2020-2031Figure 116: Latvia Hereditary Genetic Testing Market (by Neurology Genetic Testing Application), $Million, 2020-2031Figure 117: Rest-of-Europe Hereditary Genetic Testing Market, $Million, 2020-2031Figure 118: Total Number of Companies ProfiledFigure 119: Agilent Technologies, Inc.: Product PortfolioFigure 120: Agilent Technologies, Inc.: Overall Financials, 2018-2020Figure 121: Agilent Technologies, Inc.: Revenue (by Segment), 2018-2020Figure 122: Agilent Technologies, Inc.: Revenue (by Region), 2018-2020Figure 123: Agilent Technologies, Inc.: R&D Expenditure, 2018-2020Figure 124: Agilent Technologies, Inc.: SWOT AnalysisFigure 125: Woble Helsinki Oy: Product PortfolioFigure 126: Woble Helsinki Oy: SWOT AnalysisFigure 127: Negen Oy: Product PortfolioFigure 128: Negen Oy: SWOT AnalysisFigure 129: Devyser: Product PortfolioFigure 130: Devyser: SWOT AnalysisFigure 131: CeGaT GmbH: Product PortfolioFigure 132: CeGaT GmbH: SWOT AnalysisFigure 133: BGI: Product PortfolioFigure 134: BGI: SWOT AnalysisFigure 135: BerGenBio ASA: Overall Financials, 2018-2020Figure 136: BerGenBio ASA: Overall Product PortfolioFigure 137: BerGenBio ASA: SWOT AnalysisFigure 138: Eurofins Scientific SE: Overall Financials, 2018-2020Figure 139: Eurofins Scientific SE: Revenue (by Region), 2018-2020Figure 140: Eurofins Scientific SE.: SWOT AnalysisFigure 141: F. Hoffmann-La Roche Ltd: Product PortfolioFigure 142: F. Hoffmann-La Roche Ltd: Overall Financials, 2018-2020Figure 143: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2018-2020Figure 144: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2018-2020Figure 145: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2018-2020Figure 146: F. Hoffmann-La Roche Ltd: SWOT AnalysisFigure 147: Illumina, Inc.: Product PortfolioFigure 148: Illumina, Inc.: Overall Financials, 2018-2020Figure 149: Illumina, Inc.: Revenue (by Segment), 2018-2020Figure 150: Illumina, Inc.: R&D Expenditure, 2018-2020Figure 151: Illumina, Inc.: SWOT AnalysisFigure 152: Myriad Genetics, Inc.: Product PortfolioFigure 153: Myriad Genetics, Inc.: Overall Financials, 2018-2020Figure 154: Myriad Genetics, Inc.: Revenue (by Segment), 2018-2020Figure 155: Myriad Genetics, Inc.: R&D Expenditure,2018-2020Figure 156: Myriad Genetics, Inc.: SWOT AnalysisFigure 157: Alnylam Pharmaceuticals, Inc.: Overall Financials, 2018-2020Figure 158: Alnylam Pharmaceuticals, Inc.: Revenue (by Segment), 2018-2020Figure 159: Alnylam Pharmaceuticals, Inc.: Revenue (by Region), 2018-2020Figure 160: Alnylam Pharmaceuticals, Inc.: R&D Expenditure, 2018-2020Figure 161: Alnylam Pharmaceuticals, Inc.: SWOT AnalysisFigure 162: Product Portfolio: Quest Diagnostics IncorporatedFigure 163: Quest Diagnostics Incorporated: Overall Financials, 2018-2020Figure 164: Quest Diagnostics Incorporated: Revenue (by Segment), 2018-2020Figure 165: Quest Diagnostics Incorporated: SWOT AnalysisFigure 166: Thermo Fisher Scientific Inc.: Product PortfolioFigure 167: Thermo Fisher Scientific Inc.: Overall Financials, 2018-2020Figure 168: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2018-2020Figure 169: Thermo Fisher Scientific Inc.: Revenue (by Region), 2018-2020Figure 170: Thermo Fisher Scientific Inc.: R&D Expenditure, 2018-2020Figure 171: Thermo Fisher Scientific Inc.: SWOT Analysis

List of TablesTable 1: Legal and Regulatory Framework